Atlas Trials

Safety, PK, and PD Study of IVRs Releasing TFV and LNG

Clinical trial NCT03279120 · COMPLETED

Trial details

NCT number
NCT03279120
Sponsor
CONRAD
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Anti-Infective AgentsAnti-Retroviral AgentsContraceptive Usage
Start date
2017-09-28
Primary completion
2018-12-26
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.